Table 4. Prognostic impact of the immune markers in the different tumor compartments.
TILs marker and tumour compartment | OS p-value | PFS p-value | LPFS p-value | DMFS p-value |
---|---|---|---|---|
CD8 | ||||
Tumor periphery | 0.086 | 0.087 | 0.175 | 0.092 |
Tumor stroma | 0.021 | 0.034 | 0.068 | 0.004 |
Tumor intraepithelial | 0.632 | 0.320 | 0.142 | 0.567 |
FOXP3 | ||||
Tumor periphery | 0.342 | 0.456 | 0.489 | 0.390 |
Tumor stroma | 0.569 | 0.839 | 0.664 | 0.756 |
Tumor intraepithelial | 0.721 | 0.541 | 0.289 | 0.367 |
PD-1 | ||||
Tumor periphery | 0.253 | 0.048 | 0.121 | 0.025 |
Tumor stroma | 0.022 | 0.028 | 0.013 | 0.008 |
Tumor intraepithelial | 0.117 | 0.027 | 0.071 | 0.020 |
PD-L1 | ||||
Tumor periphery | 0.162 | 0.305 | 0.286 | 0.479 |
Tumor stroma | 0.259 | 0.307 | 0.259 | 0.475 |
Tumor intraepithelial | 0.162 | 0.345 | 0.268 | 0.352 |
Abbreviations: OS, overall survival; progression-free survival; PFS, progression-free survival; LPFS, local progression-free survival; DMFS, distant metastases-free survival;
Significant values have been marked with bold.